Sign In
NewsRadar

Vivet Therapeutics

Vivet Therapeutics is developing gene therapy treatments for rare, inherited metabolic diseases. It is building a pipeline based on Adeno Associated Virus (AAV) technologies. Vivet's lead program, VTX801, is an investigational gene therapy for Wilson disease. This rare genetic disorder is caused by a defective gene in liver cells encoding the ATP7B protein, which reduces the liver's ability to regulate copper levels in the liver and other tissues.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Web:
Contact:
 
 
29 rue Tronchet
Paris 75008
France
+33-684-755-087
http://www.vivet-therapeutics.com
Jean-Philippe Combal
+33-684-755-087

Company Facts
Founded:
Founders:
CEO:Jean-Philippe Combal
CTO or technical lead:
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:Early Stage
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


24,740
Tech investments
From our Online Data Service
16,005
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Sep 14€10.0MKnowledge management
Sep 14€5.0MInternet services
Sep 14€17.0MSecurity
Sep 14N/AEnergy related
Sep 14N/AInternet services
Sep 14N/AInternet services
Sep 13N/ARobotics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...

Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom

May 4
Vivet Therapeutics
vivet therapeutics raises 37.5 million in series a





About usContact usLegal Information
Copyright 1999-2018
Emerging Technology Research Europe Inc. All rights reserved.